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Abstract
Objective: The association between blood glucose and carotid intima-media thickness (CIMT) is considered to be
established knowledge. We aimed to assess whether associations between different measures of glycaemia and CIMT are
actually independent of anthropometric variables and metabolic risk factors. Moreover, we checked published studies for
the adjustment for shared risk factors of blood glucose and CIMT.
Methods: Fasting glucose, 2-hour glucose, HbA1c, and CIMT were measured in 31-81-years-old participants of the
population-based Cooperative Health Research in the Region of Augsburg (KORA) F4 study in Southern Germany (n = 2,663).
CIMT was assessed according to the Rotterdam protocol. Linear and logistic regression models with adjustment for age, sex,
anthropometric measures, hypertension, and dyslipidaemia were fitted to assess the association between continuous
measures of glycaemia, and categories of glucose regulation, respectively, with CIMT.
Results: We found a 0.10 mm increase (95%-confidence interval: 0.08–0.12) in CIMT in subjects with compared to subjects
without diabetes in crude analysis. This increase was not significant in age-sex adjusted models (p = 0.17). Likewise, neither
impaired fasting glucose (p = 0.22) nor impaired glucose tolerance (p = 0.93) were associated with CIMT after adjustment for
age, sex, and waist circumference. In multivariable adjusted models, age, sex, hypertension, waist circumference, HDL and
LDL cholesterol, but neither fasting glucose nor 2-hour glucose nor HbA1c were associated with elevated CIMT. Literature
findings are inconclusive regarding an independent association of glucose levels and CIMT.
Conclusion: CIMT is highly dependent on traditional cardiovascular risk factors, but no relationships between blood glucose
and CIMT were found after adjustment for age, sex, and anthropometric variables.
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Introduction
The association between blood glucose and carotid intima-
media thickness (CIMT) is considered to be established
knowledge as can be seen from reviews and meta-analyses [1–
4]. Moreover, such an association seems to be plausible because
both hyperglycaemia and CIMT predict cardiovascular out-
comes: CIMT is accepted as a marker of early atherosclerosis
[5–7], Type 2 diabetes is related to an increased risk of
atherosclerotic diseases [8,9], and an increase in cardiovascular
risk was observed in elevated glucose levels below the diabetic
range [10,11].
However, a closer look at the meta-analyses reveals that there
are still open questions. Components of the metabolic syndrome
do not only predict hyperglycaemia, but also the thickening of
arterial walls [12–14]. Therefore, associations between hypergly-
caemia and CIMT should be carefully adjusted for obesity,
hyperlipidaemia, and hypertension. In a meta-analysis of 11
studies, a significant correlation between postprandial glucose and
CIMT was found [2]. However, this correlation was not adjusted
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for age, sex, or other covariables. In another meta-analysis, a
difference of 0.13 mm in CIMT was reported between diabetic
and non-diabetic subjects without adjustment for covariables [3].
In a further meta-analysis of nine studies with adjustment for age,
but for no other covariables, Brohall et al. found that CIMT was
slightly larger in impaired glucose tolerance (IGT) than in normal
glucose tolerance (NGT) [4]. In their own cohort study of 64-year-
old women, however, the authors did not find an association
between IGT and CIMT after matching for BMI and waist-to-hip
ratio [4].
Only few authors attached importance to careful adjustment for
metabolic risk factors fitting several regression models with
different sets of CVD risk factors and anthropometric variables
[15–18]. Thus, the objective of the present study is to assess the
association between blood glucose and CIMT in a population-
based study. To this purpose, we will use a variety of continuous
and categorical glucose measures (fasting plasma glucose (FPG), 2-
hour plasma glucose (2hPG), HbA1c; categories of glucose
regulation according to the WHO classification [19]), and we will
systematically examine how the association between glucose and
CIMT depends on adjustment for age, sex, and CVD risk factors
like BMI, waist circumference, HDL and LDL cholesterol levels,
and hypertension. Furthermore, we will check whether literature
findings are conclusive regarding an independent association of
glucose levels and CIMT.
Methods
Study Population
The KORA S4 study is a population-based health survey
conducted in the city of Augsburg and two surrounding counties
between 1999 and 2001. Briefly, a total sample of 6640 subjects
was drawn in a two-stage cluster sample from the target
population consisting of all German residents of the region aged
25 to 74 years. Of the randomly selected 6640 subjects, 4261
(64.2%) participated in the S4 baseline study. KORA F4 is a
follow-up examination carried out 7 years after the baseline S4;
altogether 3080 persons participated in KORA F4. Loss to follow-
up was due to subjects who had died in the meantime (n= 176,
4%), lived too far outside the study region or were completely lost
to follow-up (n= 206, 5%), or had demanded deletion of their
address data (n = 12, 0.2%). Of the remaining 3867 eligible
persons, 174 could not be contacted, 218 were unable to come
because they were too ill or had no time, and 395 were not willing
to participate in this follow-up, giving a response rate of 79.6%.
Of the 3080 participants in KORA F4, 417 were excluded
because they did not have measurements of CIMT, or because
they did not have previously known diabetes, and did not undergo
complete oral glucose tolerance tests (OGTT).
Ethics Statement
The investigations were carried out in accordance with the
Declaration of Helsinki, including written informed consent of all
participants. All study methods were approved by the ethics
committee of the Bavarian Chamber of Physicians, Munich.
Ascertainment of Diabetes and Prediabetes
Self-reported diabetes cases and the date of diagnoses were
validated by contacting the general practitioners, who treated the
participants. Among all subjects without diabetes, OGTT were
performed during the morning hours (range 7:00 to 11:00 h).
Participants were asked to fast for at least 10 hours overnight, to
avoid heavy physical activity on the day before examination, and
to refrain from smoking before and during the test. Exclusion
criteria for the OGTT were known diabetes or diabetes treatment,
and acute illnesses (infection, fever, acute gastrointestinal diseases).
Fasting venous blood glucose was sampled and 75 g of anhydrous
glucose were given (Dextro OGT, Boehringer Mannheim).
Diabetes was defined by FPG $7.0 mmol/l and/or 2 h-glucose
$11.1 mmol/l. Prediabetes was divided into isolated impaired
fasting glucose (i-IFG), isolated impaired glucose tolerance (i-IGT),
and combined IFG and IGT (IFG/IGT). I-IFG was defined as
FPG $6.1, ,7.0 mmol/l and 2 h-glucose ,7.8 mmol/l. I-IGT
was defined as 2 h-glucose $7.8, ,11.1 mmol/l and FPG
,6.1 mmol/l [19].
Measurement of IMT
Two certified investigators examined extracranial carotid
arteries bilateraly with a B-mode ultrasound using 10-MHz linear
array transducer and a high resolution instrument (Sonoline G,
Siemens Medical Solutions, Munich, Germany). Ultrasound
protocol and measurements were performed according to the
protocol of the Rotterdam study [20]. Every participant had to lie
in exactly the same position following the standardized protocol
and the entire examination was continuously documented in
sound and vision on DVD. After a search for the optimal
longitudinal image for the far wall of the common carotid artery
(CCA) CCA was evaluated at 60, 90, 120, 150 and 180 degrees
marked on the Meijers Arc (right carotid artery), and at 300, 270,
240, 210 and 180 degrees (left carotid artery) and recorded on a
DVD videotape (BD-X20 1M, Firma JVC). Vertical and
horizontal calibration measurements were performed once every
week (about every 100th measurement) using an ultrasound
phantom (RMI 40466, Gammex).
Measurements of intima-media-thickness (IMT) were per-
formed off-line. Optimal scans from selected angles on both sides
were frozen on the R-wave of the ECG. Carotid IMT of the far
wall was determined over a length of 10 mm beginning at 0–5 mm
of the dilatation of the distal CCA using an automated edge
detection reading system (Prowin software, Medical Technologies
International, USA). This method has been previously described
in detail (Bots 1994), and permits the determination of mean
(average of each of the frozen images) values for the IMT on the
left and right CCA. We used the average of the measurements of 3
frozen images from both the left and right CCA to calculate artery
thickness of the distal CCA ((mean left+mean right)/2). An average
variable of left and right CIMT was calculated as dependent
variable for regression models.
One certified reader measured all IMT scans. Reproducibility
studies for IMT measurements have been performed between
paired measurements of sonographers and a second reader.
Measurements of intersonographer (n = 30 IMT measurements)
and interreader variations (n = 50 IMT measurements) revealed
coefficients of variations of 1.9% and 3.0% with Spearman
correlation coefficients of $0.89.
Anthropometric and Laboratory Measurements
Height, weight, waist circumference and blood pressure were
measured based on standardized protocols as described previously
in detail [21]. Body mass index (BMI) was calculated as weight in
kilograms divided by height squared (in square meters). Hyper-
tension was defined as blood pressure of 140/90 mm Hg or
higher, or use of antihypertensive medication given that the
subjects were aware of being hypertensive. Blood was collected
without stasis. After blood-withdrawal the blood samples were
centrifuged and kept cool (4uC) until analysis of blood glucose in
the central laboratory, which took place within a maximum of 6 h
after withdrawal. Blood glucose levels were assessed using the
Blood Glucose and Intima-Media Thickness
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hexokinase method (Glu-Flex, Dade Behring, Marburg, Ger-
many). Total cholesterol concentrations were measured according
to enzymatic methods (Chol Flex, Dade Behring, Marburg,
Germany). HbA1c was measured using the high performance
liquid chromatography method (Menarini HA-8160).
Statistical Analyses
Baseline characteristics of the study group were calculated
according to categories of glucose regulation. In linear regression
models, categorical variables of glucose regulation as well as
continuous measures of glycaemia (FPG, 2hPG, HbA1c) were used
to assess associations between glycaemia and CIMT. The linear
regression models were adjusted for age and sex, and, in addition,
for various components of the metabolic syndrome. To fulfill the
assumptions of normally distributed residuals and of homoscedas-
ticity, ln(CIMT) was used as dependent variable in the linear
regression models. Instead of the regression coefficient ß, eß is
presented which can be interpreted as the factor by which CIMT
is increased per unit of the predictor variable (or, in case of
categorical variables, as the factor by which CIMT is larger in a
given category compared to the category of reference). Logistic
regression models were conducted to predict elevated CIMT
defined as CIMT values $75th percentile. Age, sex, hypertension,
HDL and LDL cholesterol, waist circumference, and one of three
measures of glycaemia (FPG, 2hPG, HbA1c) were included in the
logistic models.
Several additional analyses were done: stratified analyses for
men and women; confinement of analyses to subjects $50 years;
separate analyses for subjects with NGT or T2DM alone;
exclusion of subjects with former myocardial infarction or stroke.
The level of statistical significance was 5%. All analyses were
performed using the SAS version 9.2 (SAS institute, Cary, NC,
USA).
Results
In the study group, 189 (7.1%) persons had previously known
diabetes, 99 (3.7%) cases of diabetes were newly detected, and 437
(16.4%) persons had prediabetes (Table 1). As expected, metabolic
profiles were most favourable in subjects with NGT, and least
advantageous in subjects with diabetes or combined IFG/IGT.
CIMT was 0.099 mm (95%-confidence interval: 0.082–0.116)
thicker in subjects with diabetes than in subjects with NGT or
prediabetes in crude analysis. However, after adjustment for age
and sex, there was no significant increase in subjects with diabetes
compared to subjects with NGT/prediabetes (p = 0.17).
Among different groups of glucose regulation (i-IFG, i-IGT,
IFG/IGT, previously undetected and previously known T2DM),
significant increases in CIMT were seen compared to NGT in
crude analyses (Table 2). Compared to subjects with NGT, CIMT
was 0.086 mm (95%-CI: 0.061–0.112) thicker in subjects with
IFG, and 0.081 mm (95%-CI: 0.064–0.098) thicker in subjects
with IGT in crude analyses. After adjustment for age and sex, a
significant increase was only seen in i-IFG compared to NGT.
After additional adjustment for waist circumference, no increase
was found among the categories of glucose regulation.
Overall, 2hPG and HbA1c were not significantly associated
with CIMT after adjustment for age and sex (Table 3). FPG was
significantly associated with CIMT after adjustment for age, sex,
and hypertension (or age, sex, and cholesterol values), but not after
adjustment for age, sex, and anthropometric measures.
In a fully adjusted logistic regression model, age, sex,
hypertension, waist circumference, HDL and LDL cholesterol
were all independently associated with elevated CIMT whereas
the association was significant neither for HbA1c nor for FPG nor
for 2hPG (Table 4).
When adjusted linear regression models as shown in Tables 2
and 3 were fitted separately for men and women, a lack of
association between blood glucose and CIMT was seen in both
sexes. In age-adjusted models, CIMT was neither elevated in men
with diabetes (eß = 1.01 (95%-CI: 0.99–1.04)) nor in women with
diabetes (eß = 1.01 (95%-CI: 0.98–1.03)) compared to men and
women without diabetes, respectively. Furthermore, in age-
adjusted models, none of the categories of glucose regulation
was associated with CIMT in men and women with the exception
of IFG and CIMT in women (eß = 1.04 (95%-CI: 1.004–1.08)
(reference: NGT)). After further adjustment for waist circumfer-
ence, the latter association was no longer significant in women
(eß = 1.03 (95%-CI: 0.99–1.07)).
After adjustment for age and waist circumference, associations
between fasting glucose, and 2-hour plasma glucose, respectively,
with CIMT were no longer significant (p = 0.15, and p=0.16,
respectively, in men; p = 0.67, and p= 0.50, respectively, in
women). Age-adjusted associations between HbA1c and CIMT
were not significant neither in men nor in women (p = 0.20, and
p= 0.93, respectively).
In fully adjusted logistic regression models, none of the three
measures of glycaemia was associated with elevated CIMT when
analyses were confined to subjects with NGT or to subjects with
diabetes (data not shown). Moreover, results shown in Table 4
were similar when subjects with previously known diabetes were
excluded, or when analyses were confined to subjects aged $50
years. Exclusion of persons with former myocardial infarction or
stroke did not alter results of Tables 2, 3, and 4.
Discussion
The main result of this population-based study is that
associations between hyperglycaemia and CIMT which were
found in crude analyses disappeared after adjustment for age, sex,
and anthropometric variables. Contrary to measures of hypergly-
caemia, traditional cardiovascular risk factors like BMI, waist
circumference, hypertension, and dyslipidaemia, were all signifi-
cantly associated with CIMT.
At first sight, this is a surprising result because there may be a
causal link between glucose and atherosclerosis through various
mechanisms like increased oxidative stress or nonenzymatic
glycosylation of proteins and lipids [22]. Nevertheless, it must be
seen that (A) literature findings about the association of glucose
levels and CIMT are more inconclusive than it may appear in the
light of published meta-analyses, and that (B) the role of
hyperglycaemia for the development of atherosclerotic diseases
may often be overestimated.
(A) Inconclusive Findings in Former Studies on
Hyperglycaemia and CIMT
When Faeh et al. included BMI in multiple linear regression
models the relationship between diabetes and CIMT was
borderline significant (p: 0.05–0.09), and it disappeared after
inclusion of waist circumference instead of BMI [16]. However, in
the ARIC study, CIMT was significantly larger in type 2 diabetes
after adjusting for BMI, cholesterol, and hypertension [18]. An
association of IFG with CIMT was not found in adjusted analyses
[16,23]. Larger CIMT values in persons with IGT compared to
NGT were not reported after matching for BMI and waist-to-hip
ratio [4]. In a prospective study, IGT did not predict CIMT levels
after adjustment for CVD risk factors and BMI [15].
Blood Glucose and Intima-Media Thickness
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Table S1 in the supplementary material gives an overview of
studies concerning the association of glycaemic measures and
CIMT. From this table, it can be seen that significant associations
between fasting glucose and CIMT were not seen in multivariate
analyses [24–28], and that results were quite ambiguous regarding
the association between 2-hour glucose, and HbA1c, respectively,
with CIMT [17,25,29–34].
(B) The Role of Hyperglycaemia for the Development of
Atherosclerosis
Various literature findings support the idea that glucose is a
risk factor for atherosclerosis, but possibly of minor importance
than traditional CVD risk factors. In a systematic review,
categories of pre-diabetes were only modestly associated with
CVD risk: For IFG (110 to 125 mg/dl), the relative risk for
eight studies was 1.12 (95%-CI: 1.00 to 1.25) compared to
NGT after adjustment for age, smoking, blood pressure and
Table 1. Characteristics of the study group by categories of glucose regulationa.
NGT i-IFG i-IGT IFG+IGT
Previously
undetected T2DM
Previously known
T2DM
N 1938 108 271 58 99 189
Sex (male) (%) 45.6 65.7 47.2 56.9 57.6 58.7
Age (years) 52.7612.5 61.0610.6 63.1611.2 64.868.8 65.1610.3 67.269.0
BMI (kg/m2) 26.764.3 29.964.7 29.564.6 31.165.2 30.964.3 31.265.4
WC (cm) 90.7612.9 102.5612.7 98.7614.0 105.0614.0 104.2611.5 105.1612.5
HT (yes) (%)b 27.5 53.7 52.8 70.7 76.8 78.3
HDL (mmol/l) 1.4960.37 1.3260.35 1.4360.37 1.3060.32 1.2560.33 1.2860.29
LDL (mmol/l) 3.4960.88 3.7460.94 3.7660.94 3.7760.80 3.5660.92 3.2760.90
Triglycerides (mmol/l) 1.07 (0.75, 1.54) 1.48 (1.15, 2.16) 1.37 (1.02, 1.94) 1.93 (1.33, 2.69) 1.65 (1.17, 2.62) 1.57 (1.14, 2.27)
HbA1c (mmol/mol) 3563 3964 3864 4164 44610 52612
HbA1c [%] 5.460.3 5.760.3 5.660.3 5.960.3 6.260.9 6.961.1
FPG (mmol/l) 5.160.4 6.360.2 5.460.4 6.560.2 6.861.4 7.962.0
2hPG (mmol/l) 5.461.2 6.160.9 8.960.9 9.361.0 12.063.2 –
IMTc (mm) 0.8360.13 0.9160.13 0.9160.14 0.9160.14 0.9360.14 0.9460.13
NGT: normal glucose tolerance; IFG: impaired fasting glucose; IGT: impaired glucose tolerance; i-IFG: isolated impaired fasting glucose; i-IGT: isolated impaired glucose
tolerance; T2DM: type 2 diabetes; BMI: body mass index; WC: waist circumference; HT: hypertension; HDL: high density lipoprotein cholesterol; LDL: low density
lipoprotein cholesterol; FPG: fasting plasma glucose; 2hPG: 2-hour plasma glucose; IMT: intima media thickness.
amean 6 standard deviation, median (first quartile, third quartile).
bblood pressure of 140/90 mm Hg or higher, or antihypertensive medicine.
caverage IMT of right and left common carotid artery.
doi:10.1371/journal.pone.0052590.t001
Table 2. Linear regression models with logarithm of carotid intima media thickness as dependent and glucose tolerance category
as independent variable (eß (95%-CI))a.
Model 1 Model 2 Model 3 Model 4
eß (95%-CI) p eß (95%-CI) p eß (95%-CI) p eß (95%-CI) p
T2DM 1.12 (1.10–1.14) ,0.001 1.01 (0.996–1.03) 0.17 1.00 (0.99–1.01) 0.94 1.00 (0.99–1.02) 0.87
NGT or prediabetes 1 (ref) 1 (ref) 1 (ref) 1 (ref)
known T2DM 1.14 (1.12–1.17) ,0.001 1.01 (0.99–1.03) 0.21 1.00 (0.98–1.02) 0.80 1.00 (0.98–1.02) 0.97
undetected T2DM 1.13 (1.10–1.17) ,0.001 1.02 (0.99–1.04) 0.17 1.00 (0.98–1.03) 0.74 1.00 (0.98–1.03) 0.80
IFG+IGT 1.11 (1.06–1.15) ,0.001 1.00 (0.97–1.03) 0.84 0.98 (0.95–1.01) 0.27 0.98 (0.95–1.01) 0.18
i-IGT 1.10 (1.08–1.12) ,0.001 1.01 (0.99–1.02) 0.29 1.00 (0.99–1.02) 0.93 1.00 (0.98–1.01) 0.88
i-IFG 1.11 (1.07–1.14) ,0.001 1.03 (1.002–1.05) 0.03 1.01 (0.99–1.04) 0.22 1.01 (0.99–1.03) 0.30
NGT 1 (ref) 1 (ref) 1 (ref) 1 (ref)
CI: confidence interval; T2DM: type 2 diabetes; NGT: normal glucose tolerance; IFG: impaired fasting glucose; IGT: impaired glucose tolerance;
i-IFG: isolated impaired fasting glucose; i-IGT: isolated impaired glucose tolerance.
aFor the interpretation of eß compare the methods section.
Model 1: crude model.
Model 2: adjusted for age and sex.
Model 3: adjusted for age, sex, and waist circumference.
Model 4: adjusted for age, sex, waist circumference, HDL cholesterol, LDL cholesterol, triglycerides, hypertension.
doi:10.1371/journal.pone.0052590.t002
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lipids; for IGT, the summary estimate was 1.20 (95%-CI: 1.06
to 1.35) in six studies with adjustment for the same variables
[35].
Stern et al. developed a model for the prediction of
cardiovascular diseases which included age, sex, ethnicity, lipids,
blood pressure, BMI, family history and smoking as traditional
CVD risk factors. Addition of 2-hour plasma glucose to this
multivariate model led to an only marginal increase of the area
under the receiver operating curve of 0.1% [36]. Accordingly,
Meigs et al. found that fasting glucose was not an independent
risk factor for CVD when it was added to a prediction model
including sex and CVD risk factors [37]. 2-hour plasma glucose
led to a significant, albeit only marginal improvement of
diabetes prediction.
Chamnan et al. found that subjects with HbA1c ,5.5%
(,37 mmol/mol) and unfavourable cardiovascular risk profiles
have a more than 10-fold larger risk of CVD than subjects with
HbA1c of 6.0 to 6.4% (42 to 46 mmol/mol) and favourable
cardiovascular risk profiles [38]. The authors did not question
the role of hyperglycaemia as a CVD risk factor, but like our
study these results demonstrate the great importance of
traditional risk factors for atherosclerosis. This can also be seen
from a recently published study with Chinese participants: male
gender, age, BMI, hypertension, and LDL cholesterol were
significant determinants of CIMT, whereas fasting glucose was
not associated with CIMT in a multivariate regression model
[39].
In the ARIC study, an association between a fasting glucose
genetic risk score and IMT was found (p= 0.009) [40]. However,
the difference for one standard deviation of the score was only
0.0048 mm and hence not clinically relevant, and, moreover, the
analysis was adjusted for age, sex, and study centre, but not for
metabolic risk factors. The authors did not exclude that the
association between the genetic risk score and IMT might be due
to nonglucose pathways.
Limitations and Strengths
One limitation of our study is its cross-sectional design so that
the temporality of associations between glucose levels and CIMT
could not be assessed. Moreover, glucose levels were measured
only once so that some individuals might be inaccurately
diagnosed. Our study has several strengths. It is a population-
based study with a large sample size, and CIMT has been
measured according to the Rotterdam protocol. Several categor-
ical and continuous measures of glycaemia were included in the
analyses. To assess associations of glucose levels with CIMT,
different sets of potential confounders were used. Finally, our
findings were robust and were confirmed after changes of analysis
strategies (for example, exclusion of previously known diabetes; sex
and age stratification; using CIMT as a continuous and as a
dichotomous variable).
Conclusion
In this population-based study, traditional CVD risk factors,
but none of the measures of hyperglycaemia were independently
associated with CIMT. There is still a lack of studies where the
relationship between blood glucose and CIMT is assessed with
careful adjustment for risk factors, and there is a lack of
prospective studies to see whether blood glucose levels predict
CIMT. In a public health perspective, our results suggest that
targeting subjects for the prevention of early atherosclerosis
should not primarily be directed to categories of glucose like
Table 3. Linear regression models with logarithm of carotid intima media thickness as dependent variable and glycaemic
measures as independent variables (eß (95%-CI))a.
FPGb 2hPGb HbA1cc
Adjustment eß (95%-CI) p eß (95%-CI) p eß (95%-CI) p
age and sex 1.007 (1.002–1.011) 0.003 1.002 (0.999–1.004) 0.17 1.005 (0.997–1.013) 0.26
age, sex, and HT 1.005 (1.000–1.009) 0.04 1.001 (0.998–1.003) 0.65 1.001 (0.993–1.009) 0.78
age, sex, HDL, LDL 1.005 (1.000–1.009) 0.04 1.000 (0.998–1.002) 0.88 1.000 (0.992–1.008) 0.96
age, sex, and WC 1.002 (0.998–1.007) 0.30 0.999 (0.997–1.002) 0.51 0.998 (0.990–1.006) 0.55
age, sex, and BMI 1.003 (0.998–1.007) 0.25 0.999 (0.997–1.001) 0.48 0.999 (0.991–1.007) 0.72
full adjustmentd 1.003 (0.998–1.008) 0.21 0.999 (0.996–1.001) 0.34 0.997 (0.989–1.005) 0.49
CI: confidence interval; FPG: fasting plasma glucose; 2hPG: 2-hour plasma glucose; HT: hypertension; HDL: high density lipoprotein.
cholesterol; LDL: low density lipoprotein cholesterol; WC: waist circumference; BMI: body mass index.
aFor the interpretation of eß compare the methods section.
bper mmol/l.
cper %.
dadjusted for age, sex, waist circumference, HDL cholesterol, LDL cholesterol, triglycerides, hypertension.
doi:10.1371/journal.pone.0052590.t003
Table 4. Risk factors of carotid intima media thickness ($75th
percentile): Multivariate logistic regression model.
Risk factor OR (95%-CI)
Age (per year) 1.12 (1.11–1.14)*
Sex (male versus female) 1.44 (1.13–1.82)*
Hypertension (yes versus no) 1.44 (1.14–1.81)*
HDL cholesterol (per mmol/l) 0.64 (0.45–0.90)*
LDL cholesterol (per mmol/l) 1.35 (1.20–1.52)*
Waist circumference (per cm) 1.02 (1.01–1.03)*
Fasting plasma glucose (per mmol/l)a 1.03 (0.94–1.14)
OR: odds ratio; CI: confidence interval; HDL: high density lipoprotein; LDL:
low density lipoprotein.
*p,0.05.
aWhen fasting plasma glucose was exchanged for 2-hour plasma glucose.
and for HbA1c, respectively, ORs (95%-CI) were as follows:
2-hour plasma glucose (per mmol/l): 0.98 (0.92–1.03).
HbA1c (per %): 1.10 (0.92–1.31).
doi:10.1371/journal.pone.0052590.t004
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IFG and IGT, but take into account the whole spectrum of
traditional CVD risk factors including glucose.
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